Abstract

Abstract SY19-04: Design and development of ponatinib, a pan-BCR-ABL inhibitor for CML.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call